Arcus Biosciences
RCUS
RCUS
64 hedge funds and large institutions have $322M invested in Arcus Biosciences in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 67 → 64 (-3)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
Holders
64
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$4.98M | |
| 2 | +$1.37M | |
| 3 | +$596K | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$528K |
| 5 |
State Street
Boston,
Massachusetts
|
+$389K |
Top Sellers
| 1 | -$8.27M | |
| 2 | -$4.17M | |
| 3 | -$2.91M | |
| 4 |
ACM
Aisling Capital Management
New York
|
-$2.54M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.38M |